President Donald Trump’s first term championed a vision of American healthcare rooted in innovation, patient choice, and ...

Ultragenyx (RARE) stock is down 40% since March 2024 amid ongoing financial struggles. See more insights on its growth ...

Denali Therapeutics faces an FDA review delay for its Hunter syndrome drug, pushing potential approval of tividenofusp alfa to April 2026.

The disease gradually takes away the skills children have learned—leading to seizures, movement difficulties and profound ...

Detailed price information for Spruce Biosciences Inc (SPRB-Q) from The Globe and Mail including charting and trades.

The stock market was mixed, with AMD and Nvidia lifting the S&P 500 and Nasdaq to highs while the Dow Jones fell. Tesla launched cheap EVs.

Update: On Thursday, the Texas Court of Criminal Appeals stayed Roberson's execution that was scheduled for next week and sent the case back to the trial court. Read more here. Robert Roberson was ...

I started the Rare Dads RoundTables for fathers of special-needs children with rare diseases because I realized most dads don ...

In her self-titled Netflix docuseries, the star reveals how the media's hyper-focus on her appearance affected her "sense of reality" Lizzie Hyman is a Writer-Reporter for PEOPLE, where she ...

Alexandria Ocasio-Cortez has apologised for body-shaming one of Donald Trump’s most senior staff members. The firebrand Democrat congresswoman claimed Stephen Miller, Mr Trump’s deputy chief of staff, ...

Shares of Spruce Biosciences were lower after the company said it had agreed to sell shares in a private placement expected to raise $50 million in gross proceeds. The stock fell 23% to $140 in ...

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need ...